Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast ButtonSwitch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Stay Informed: Medical and Research Updates
Connect With Us!
 

 

Tau Disrupts Neural Communication Prior To Neurodegeneration

December 22, 2010

On behalf of our donors, Alzheimer's Disease Research (ADR), a program of the BrightFocus Foundation, recognizes Dr. Liao, a BrightFocus grantee, for his work on this important study.

Dr. Dezhi Liao and co‚Äźauthors discovered that part of the memory loss from Alzheimer's disease is not due to cell death, but caused by a buildup of tau protein in the parts of the nerve cell, called the “dendritic spines,” that are used to store memories. Specifically, tau is forced to go where it shouldn't by a change called phosphorylation. In a laboratory study, when the researchers used genetically-modified tau proteins that couldn't be phosphorylated, they also blocked the damaging tau protein buildup in rat nerve cells. In the future, a new drug could be developed to prevent this phosphorylation and stop tau from entering the dendritic spines, potentially halting the loss of memories in early stages of Alzheimer's disease.

Adapted from Cell Press

A new study is unraveling the earliest events associated with neurodegenerative diseases characterized by abnormal accumulation of tau protein.  The research, published by Cell Press in the December 22 issue of the journal Neuron, reveals how tau disrupts neuronal communication at synapses and may help to guide development of therapeutic strategies that precede irreversible neuronal degeneration.

Tau normally contributes to the supportive framework of proteins in the cell. It is well established that abnormal tau sometimes clumps into neuron-damaging filamentous deposits and that aggregates of tau with multiple phosphate groups attached are a defining feature of neurodegenerative disorders called “tauopathies”, which include Alzheimer's disease and other dementias.

“Research has shown that healthy neurons have more tau in the axon and less in the cell body and dendrites, and that this gradient is reversed in neurodegenerative disorders like Alzheimer's,” explains study author, Dr. Karen H. Ashe from the University of Minnesota. “Although studies have shown that accumulation of tau in dendrites induced neurodegeneration, they do not address how tau diminished brain function at preclinical disease stages preceding neurodegeneration.”   

Dr. Ashe, co-author Dr. Dezhi Liao, and their colleagues investigated how tau induces early memory deficits and disrupts neuronal communication, prior to obvious neuron damage. The researchers found that early accumulation of hyperphosphorylated tau in dendrites and dendritic spines disrupted communication coming in from other neurons.  Dendritic spines are sites where there is a synapse between two neurons. The phosphorylation state of tau played a critical role in mediating tau mislocalization and subsequent impairment of synaptic communication.

“These findings capture what is likely the earliest synaptic dysfunction that precedes synapse loss in tauopathies and provide an important mechanistic link between tau phosphorylation and the mislocalization of tau to dendritic spines,” concludes Dr. Liao. “Understanding the  key interactions that occur  prior to neuronal loss will become increasingly important as preventative strategies shift the timing of interventions to pre-degenerative phases of disease,” adds Dr. Ashe. “The aberrant mislocalization of tau proteins in dendritic spines might be a novel target in these strategies.”

 

View all news updates for Alzheimer's disease


Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.

::

]]

Shop for a Cause YouTube Twitter Connect With Us Pinterest Google+